Kenvue shares tumbled more than 10% on Friday after a Wall Street Journal report revealed that Health and Human Services Secretary Robert F. Kennedy Jr. plans to link prenatal use of Tylenol, one of the company’s best-selling products, to autism in an upcoming federal report, a move that has rattled investors. Kennedy is reportedly preparing… The post Kenvue shares dip 10% as RFK Jr. connects Tylenol use in pregnancy with autism appeared first on Research & Development World.
